Early Implications of the Zika Virus for the U.S. Diagnostics Market

Early Implications of the Zika Virus for the U.S. Diagnostics Market

In addition to its blog posts regarding infectious disease threats, Kalorama Information offers a comprehensive market research report for global infectious disease testing.

Since the last blog entry regarding Zika virus diagnostics, the U.S. Centers for Disease Control and Prevention (CDC) has issued emergency use authorizations (EUA) for a Zika IgM Antibody Capture ELISA (MAC-ELISA) kit and real-time reverse transcriptase PCR (RT-PCR) kit. Controls and kit reagents are available through the ...


Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Kalorama Information offers additional analysis of the markets discussed below with an upcoming title on clinical and research microarrays as well as published reports including The Market for Prenatal, Newborn and Carrier Genetic Testing , The World Market for Cancer Diagnostics, 6 th Ed. , Proteomics Research Markets , The World Market for Flow Cytometry in IVD Applications , and The World Market for Veterinary Diagnostics.

Thermo Fisher Scientific’s reach in the global life sciences market ...


Propelled by NIPT, China Moves to the Fore in NGS Assays

Propelled by NIPT, China Moves to the Fore in NGS Assays

China is playing an increasingly significant role not only in the IVD industry, but global clinical markets. Kalorama Information offers comprehensive subject reports that variously treat the Chinese IVD , global cancer diagnostics , prenatal testing , circulating tumor cells (CTCs) , and next-generation sequencing (NGS) markets.

The stakes are high for clinical next-generation sequencing (NGS) platform vendors in the Chinese market. In 2014, the Chinese Food & Drug Administration (CFDA; SFDA)...


Catch Up on Prenatal and Neonatal Testing Technologies and Industry Moves with Kalorama’s Clinical OMICs Article

Catch Up on Prenatal and Neonatal Testing Technologies and Industry Moves with Kalorama’s Clinical OMICs Article

Kalorama Information provides comprehensive insights into the prenatal and neonatal testing markets and industry with The Market for Prenatal, Newborn and Carrier Genetic Testing. Read more regarding the market with Kalorama’s article in Clinical OMICs - Prenatal Testing Upgraded with Sequencing, Microarrays and Mass Spec.

The prenatal testing market has become, technologically speaking, quite diverse in less than 10 years. Industry stalwart PerkinElmer serves as an effective case study as it ...


Ariosa Matches Sequenom-Illumina with NIPT LDT Licensing Move

Following the agreement between Sequenom and Illumina earlier this year allowing the latter to license pooled non-invasive prenatal testing (NIPT) IP to third-party labs worldwide, Roche Diagnostics’ Ariosa Diagnostics announced this week that it would grant licenses to labs for its own technology relating to NIPT. The three major players in prenatal testing operate their own labs to perform NIPT services on sent-out samples, but have encouraged outside labs to adopt their technologies in order ...


Carrier, Prenatal and Pediatric Genetic Testing Still a Big Draw for Investors and Labs

Carrier, Prenatal and Pediatric Genetic Testing Still a Big Draw for Investors and Labs

Genetic testing for inherited diseases has been a volatile industry space in recent years headlined by Myriad Genetics’ hold over BRCA testing and the subsequent opening of that market to competition with a 2013 Supreme Court ruling. Outside of testing for patient testing for oncology risk, a significant component of genetic testing is reproductive health-oriented testing for carrier genes and prenatal conditions. Atop the high-growth market for non-invasive prenatal testing (NIPT) are Sequenom ...